chitosan lauramide succinamide hamilelikte güvenli mi?
No harmonised CLP classification (no H360/H361) or SCCS/CIR safety assessment was found for this specific INCI. The ingredient is listed in the EU cosmetic ingredient inventories (CosIng / Official Journal list) as a cosmetic chitosan derivative but I found no reproductive toxicity or human teratogenicity data for this specific derivative. General chitosan/chitosan-oligosaccharide literature does not indicate established teratogenicity. Sources: EU ingredient listing, EWG entry, and PubMed review of chitosan oligosaccharides (no adverse reproductive signal).
Related ingredients
Frequently asked questions
- chitosan lauramide succinamide hamilelikte güvenli mi?
- No harmonised CLP classification (no H360/H361) or SCCS/CIR safety assessment was found for this specific INCI. The ingredient is listed in the EU cosmetic ingredient inventories (CosIng / Official Journal list) as a cosmetic chitosan derivative but I found no reproductive toxicity or human teratogenicity data for this specific derivative. General chitosan/chitosan-oligosaccharide literature does not indicate established teratogenicity. Sources: EU ingredient listing, EWG entry, and PubMed review of chitosan oligosaccharides (no adverse reproductive signal).
- chitosan lauramide succinamide emzirirken güvenli mi?
- No data located indicating reproductive or lactation-related hazard, no harmonised classification, and no SCCS/CIR contraindication for breastfeeding. Topical cosmetic use of polymeric chitosan derivatives typically shows low systemic absorption; no studies found showing transfer into breast milk for this derivative.
- chitosan lauramide succinamide bebek cildi için güvenli mi?
- No specific infant-skin safety or absorption studies were located for chitosan lauramide succinamide. Following your scoring rules, because there is measurable (but low) potential for topical absorption for modified chitosan derivatives and infants have higher surface-area-to-weight and immature barrier, exposure (e) is increased by +1 vs adult (from 0 to 1). No infant-specific hazard or mechanism evidence was found to raise h or m.
- VeriMom chitosan lauramide succinamide nasıl puanlıyor?
- VeriMom chitosan lauramide succinamide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte chitosan lauramide succinamide yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.